Among the genetic abnormalities in MM, the t(4;14) translocation occurs in 15%–20% of patients, leading to FGFR3 (fibroblast growth factor receptor 3) and MMSET (multiple myeloma SET domain) overexpression. Here, NSD2 is linked to Miyoshi myopathy.